AbbVie, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical Research and Development

Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.

CEO Name:
Richard Gonzalez
Director, State Government Affairs

Contact
CL
Christina Lee
1 North Waukegan Road, ABV1, 3-C
North Chicago, IL 60064
(847) 938-8522
christina.lee@abbvie.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Christina Lee Exclusive Duties N/A Authorized On 10/5/2017 Withdrawn On N/A
William J McCoshen Exclusive Duties N/A Authorized On 10/30/2017 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 679
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

For
Notification Date
12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

2017 Wisconsin Act 149

For
Notification Date
12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

LRB 4734/1
Development, drafting or introduction of a proposal relating to
LRB 4734/1

Action Intended To Affect
Both Legislative matter and rule

Notification Date
11/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Biosimilar substitution for interchangeables, as deemed by the FDA
Development, drafting or introduction of a proposal relating to
Biosimilar substitution for interchangeables, as deemed by the FDA

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/31/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
July - December
$41,230.00
2018
January - June
$25,163.17
2018
July - December
$0.00
Total $66,393.17
Total Hours Communicating 2017
July - December
47.00
2018
January - June
50.00
2018
July - December
0.00
Total 97.00
Total Hours Other 2017
July - December
189.00
2018
January - June
80.00
2018
July - December
0.00
Total 269.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
20 %
2018
January - June
90 %
2018
July - December
Total 45 %
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
10 %
2018
July - December
Total 4 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
36 %
2018
January - June
2018
July - December
Total 23 %
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
44 %
2018
January - June
2018
July - December
Total 28 %

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
2018
July - December
100 %
Total < 1%

Filed Statements of Lobbying Activity and Expenditures